NCT01889290View on ClinicalTrials.gov

Methylnaltrexone Pharmacokinetics in Neurointensive Care Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Opioid Use, Unspecified With Other Opioid-induced Disorder
Interventions
DRUG

Methylnaltrexone

Methylnaltrexone 12mg s.c. administered once daily until treatment stop of sufentanyl

Trial Locations (1)

Unknown

Neurointensive Care Unit, Zurich

All Listed Sponsors
lead

University of Zurich

OTHER

NCT01889290 - Methylnaltrexone Pharmacokinetics in Neurointensive Care Patients | Biotech Hunter | Biotech Hunter